PRISM
Problem: repeated emotional decisions. Use: make pressure, risk, and FOMO patterns visible. Next: complete free Core and keep the result in your panel.
TupTraderTrader growth path
This page is for real user questions: from starting the path to product access, Journal, Replay, and tools.
TupTraderThis guide is about using the products. Pick a suggested question or write the product you want to use.
You do not need to understand everything at once. Start with the part that answers today’s concern.
Problem: repeated emotional decisions. Use: make pressure, risk, and FOMO patterns visible. Next: complete free Core and keep the result in your panel.
Problem: scattered learning. Use: short chapters, practice, and a trackable path. Next: open the chapter map and start with free lessons.
Problem: memory fades after trades. Use: log entry reason, exit reason, emotion, and repeated errors. Next: start with Journal Trace and compare Journal Review if you need deeper review.
Problem: live pressure arrives before practice. Use: review scenarios, record decisions, and inspect reaction. Next: run free Replay and connect mistakes to Journal.
Problem: noisy charts and rushed decisions. Use: show market evidence through controlled access. Next: read each indicator page and compare tool levels.
Problem: repeated execution errors. Use: support operational discipline with licensing and clear limits. Next: review access and risk terms before activation.
Problem: advanced users need execution, risk, and access control. Use: controlled rollout and trackable preparation. Next: follow the countdown and readiness path.
Open the question; if the answer is not enough, send a message from this page.
Start with PRISM Snapshot so the suggested path and lesson priority become clear.
Academy shows the first nodes now; each node can become a separate lesson later.
After account, payment, and entitlement, access activates in the user panel. Tool files are not directly hosted.
Use the partnership page to submit a ticket-like request for admin review.